×

Spiro[2.4]heptanes for treatment of flaviviridae infections

  • US 8,921,384 B2
  • Filed: 01/23/2014
  • Issued: 12/30/2014
  • Est. Priority Date: 02/14/2012
  • Status: Active Grant
First Claim
Patent Images

1. A method for the treatment of a hepatitis C infection in a host in need thereof, comprising administering an effective amount of a spiro[2.4]heptane of the following structure:

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×